$2.76 Billion is the total value of Tekla Capital Management LLC's 212 reported holdings in Q3 2018. The portfolio turnover from Q2 2018 to Q3 2018 was 0.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ALXN | Alexion Pharmaceuticals, Inc. | $60,944,000 | +12.0% | 438,416 | 0.0% | 2.21% | +7.0% | |
| MYL | Mylan N.V.shares | $60,647,000 | +1.3% | 1,657,017 | 0.0% | 2.20% | -3.3% | |
| REGN | Regeneron Pharmaceuticals, Inc. | $59,086,000 | +17.1% | 146,237 | 0.0% | 2.14% | +12.0% | |
| AGN | Allergan plcshares | $47,398,000 | +14.3% | 248,836 | 0.0% | 1.72% | +9.2% | |
| INCY | Incyte Corporation | $44,587,000 | +3.1% | 645,442 | 0.0% | 1.62% | -1.5% | |
| SGEN | Seattle Genetics, Inc. | $21,549,000 | +16.2% | 279,417 | 0.0% | 0.78% | +11.1% | |
| SAGE | Sage Therapeutics, Inc. | $20,285,000 | -9.8% | 143,614 | 0.0% | 0.74% | -13.7% | |
| OHI | Omega Healthcare Investors, Inc. | $19,000,000 | +5.7% | 579,785 | 0.0% | 0.69% | +1.0% | |
| JAZZ | Jazz Pharmaceuticals plcshares | $18,570,000 | -2.4% | 110,452 | 0.0% | 0.67% | -6.8% | |
| SBRA | Sabra Health Care REIT, Inc. | $16,753,000 | +6.4% | 724,606 | 0.0% | 0.61% | +1.7% | |
| ZBH | Zimmer Biomet Holdings, Inc. | $15,625,000 | +18.0% | 118,846 | 0.0% | 0.57% | +12.7% | |
| BMRN | BioMarin Pharmaceutical Inc. | $13,628,000 | +2.9% | 140,538 | 0.0% | 0.49% | -1.6% | |
| PIRS | Pieris Pharmaceuticals, Inc. | $11,689,000 | +10.5% | 2,087,380 | 0.0% | 0.42% | +5.5% | |
| BPMC | Blueprint Medicines Corporation | $11,397,000 | +23.0% | 146,001 | 0.0% | 0.41% | +17.3% | |
| SNH | Senior Housing Properties Trust | $11,353,000 | -2.9% | 646,554 | 0.0% | 0.41% | -7.2% | |
| FGEN | FibroGen, Inc. | $10,826,000 | -3.0% | 178,207 | 0.0% | 0.39% | -7.1% | |
| FOLD | Amicus Therapeutics, Inc. | $10,582,000 | -22.6% | 875,304 | 0.0% | 0.38% | -26.0% | |
| XLRN | Acceleron Pharma Inc. | $9,773,000 | +17.9% | 170,766 | 0.0% | 0.35% | +12.7% | |
| Aegerion Pharmaceuticals, Inc.note 2.00% 8/15/19 | $9,740,000 | +15.5% | 13,000,000 | 0.0% | 0.35% | +10.3% | ||
| ACHC | Acadia Healthcare Company, Inc. | $9,588,000 | -14.0% | 272,400 | 0.0% | 0.35% | -17.7% | |
| LTC | LTC Properties, Inc. | $9,249,000 | +3.2% | 209,673 | 0.0% | 0.34% | -1.5% | |
| DPLO | Diplomat Pharmacy, Inc. | $8,521,000 | -24.1% | 439,001 | 0.0% | 0.31% | -27.5% | |
| CI | Cigna Corporation | $8,426,000 | +22.5% | 40,461 | 0.0% | 0.31% | +17.2% | |
| ESPR | Esperion Therapeutics, Inc. | $8,399,000 | +13.2% | 189,287 | 0.0% | 0.30% | +8.5% | |
| MRUS | Merus N.V. | $8,175,000 | -13.3% | 414,115 | 0.0% | 0.30% | -17.3% | |
| SNY | Sanofisponsored adr | $8,036,000 | +11.6% | 179,900 | 0.0% | 0.29% | +6.6% | |
| CRSP | CRISPR Therapeutics AG | $7,910,000 | -24.5% | 178,348 | 0.0% | 0.29% | -27.9% | |
| WMGI | Wright Medical Group N.V.ordinary shares | $7,742,000 | +11.8% | 266,781 | 0.0% | 0.28% | +6.8% | |
| ALKS | Alkermes plcshares | $7,259,000 | +3.1% | 171,042 | 0.0% | 0.26% | -1.5% | |
| RMD | ResMed Inc. | $6,762,000 | +11.3% | 58,630 | 0.0% | 0.24% | +6.5% | |
| DOC | Physicians Realty Trust | $6,593,000 | +5.8% | 391,016 | 0.0% | 0.24% | +0.8% | |
| SHPG | Shire plcshares | $6,565,000 | +7.4% | 36,216 | 0.0% | 0.24% | +2.6% | |
| RARE | Ultragenyx Pharmaceutical Inc. | $5,875,000 | -0.7% | 76,958 | 0.0% | 0.21% | -4.9% | |
| VTR | Ventas, Inc. | $5,356,000 | -4.5% | 98,496 | 0.0% | 0.19% | -8.9% | |
| UTHR | United Therapeutics Corporationclass b | $5,276,000 | +13.0% | 41,261 | 0.0% | 0.19% | +7.9% | |
| EPZM | Epizyme, Inc. | $5,144,000 | -21.8% | 485,325 | 0.0% | 0.19% | -25.2% | |
| THC | Tenet Healthcare Corporation | $4,682,000 | -15.2% | 164,500 | 0.0% | 0.17% | -19.0% | |
| ARNA | Arena Pharmaceuticals, Inc. | $4,315,000 | +5.6% | 93,767 | 0.0% | 0.16% | +0.6% | |
| IONS | Ionis Pharmaceuticals, Inc. | $4,273,000 | +23.8% | 82,838 | 0.0% | 0.16% | +18.3% | |
| ALBO | Albireo Pharma, Inc. | $4,120,000 | -7.2% | 125,000 | 0.0% | 0.15% | -11.3% | |
| PBYI | Puma Biotechnology, Inc. | $3,821,000 | -22.5% | 83,340 | 0.0% | 0.14% | -25.7% | |
| TSRO | TESARO, Inc. | $3,705,000 | -12.3% | 94,970 | 0.0% | 0.13% | -16.2% | |
| PRAH | PRA Health Sciences, Inc. | $3,577,000 | +18.1% | 32,460 | 0.0% | 0.13% | +13.0% | |
| AVDL | Avadel Pharmaceuticals plcsponsored adr | $3,576,000 | -28.4% | 814,588 | 0.0% | 0.13% | -31.2% | |
| VRNA | Verona Pharma plcsponsored adr | $3,440,000 | -9.0% | 275,000 | 0.0% | 0.12% | -12.6% | |
| HZNP | Horizon Pharma plcshares | $3,190,000 | +18.2% | 162,900 | 0.0% | 0.12% | +13.7% | |
| SNR | New Senior Investment Group Inc. | $3,121,000 | -22.1% | 528,919 | 0.0% | 0.11% | -25.7% | |
| CRL | Charles River Laboratories International, Inc. | $3,050,000 | +19.8% | 22,670 | 0.0% | 0.11% | +14.4% | |
| OVID | Ovid Therapeutics Inc. | $3,038,000 | -27.3% | 535,824 | 0.0% | 0.11% | -30.8% | |
| VAR | Varian Medical Systems, Inc. | $2,936,000 | -1.6% | 26,227 | 0.0% | 0.11% | -6.2% | |
| WELL | Welltower Inc. | $2,930,000 | +2.6% | 45,560 | 0.0% | 0.11% | -1.9% | |
| ARDX | Ardelyx, Inc. | $2,781,000 | +17.5% | 639,370 | 0.0% | 0.10% | +12.2% | |
| Trillium Therapeutics Inc. | $2,717,000 | -3.3% | 468,399 | 0.0% | 0.10% | -7.5% | ||
| HSIC | Henry Schein, Inc. | $2,670,000 | +17.1% | 31,400 | 0.0% | 0.10% | +11.5% | |
| PRGO | Perrigo Company plcshares | $2,641,000 | -2.9% | 37,300 | 0.0% | 0.10% | -6.8% | |
| DERM | Dermira, Inc. | $2,553,000 | +18.5% | 234,200 | 0.0% | 0.09% | +13.4% | |
| INVA | Innoviva, Inc. | $2,463,000 | +10.4% | 161,603 | 0.0% | 0.09% | +4.7% | |
| TTPH | Tetraphase Pharmaceuticals, Inc. | $2,372,000 | -22.7% | 859,322 | 0.0% | 0.09% | -25.9% | |
| ARPO | Aerpio Pharmaceuticals, Inc. | $2,364,000 | -25.5% | 765,000 | 0.0% | 0.09% | -28.3% | |
| AKBA | Akebia Therapeutics, Inc. | $2,354,000 | -11.5% | 266,612 | 0.0% | 0.08% | -15.8% | |
| PTGX | Protagonist Therapeutics, Inc. | $2,254,000 | +53.1% | 219,042 | 0.0% | 0.08% | +46.4% | |
| CLVS | Clovis Oncology, Inc. | $2,214,000 | -35.4% | 75,400 | 0.0% | 0.08% | -38.5% | |
| HR | Healthcare Realty Trust Incorporated | $1,990,000 | +0.7% | 68,000 | 0.0% | 0.07% | -4.0% | |
| ACAD | ACADIA Pharmaceuticals Inc. | $1,945,000 | +35.9% | 93,689 | 0.0% | 0.07% | +31.5% | |
| RVNC | Revance Therapeutics, Inc. | $1,936,000 | -9.5% | 77,919 | 0.0% | 0.07% | -13.6% | |
| CBAY | CymaBay Therapeutics, Inc. | $1,883,000 | -17.4% | 169,962 | 0.0% | 0.07% | -21.8% | |
| TFX | Teleflex Incorporated | $1,697,000 | -0.8% | 6,379 | 0.0% | 0.06% | -4.6% | |
| SNDX | Syndax Pharmaceuticals, Inc. | $1,616,000 | +15.1% | 200,000 | 0.0% | 0.06% | +11.3% | |
| ACIU | AC Immune SAshares | $1,375,000 | -14.0% | 171,813 | 0.0% | 0.05% | -18.0% | |
| NUVA | NuVasive, Inc. | $1,390,000 | +36.1% | 19,580 | 0.0% | 0.05% | +28.2% | |
| QURE | uniQure N.V.shares | $1,373,000 | -3.8% | 37,741 | 0.0% | 0.05% | -7.4% | |
| ONCE | Spark Therapeutics, Inc. | $1,203,000 | -34.1% | 22,046 | 0.0% | 0.04% | -36.2% | |
| HTA | Healthcare Trust of America, Inc. | $1,227,000 | -1.0% | 46,000 | 0.0% | 0.04% | -6.4% | |
| HCP | HCP, Inc. | $1,198,000 | +2.0% | 45,500 | 0.0% | 0.04% | -4.4% | |
| NVAX | Novavax, Inc. | $1,073,000 | +40.3% | 571,000 | 0.0% | 0.04% | +34.5% | |
| LMAT | LeMaitre Vascular, Inc. | $1,052,000 | +15.7% | 27,150 | 0.0% | 0.04% | +11.8% | |
| HOLX | Hologic, Inc. | $801,000 | +3.1% | 19,546 | 0.0% | 0.03% | 0.0% | |
| MTEM | Molecular Templates, Inc. | $777,000 | +3.1% | 144,110 | 0.0% | 0.03% | -3.4% | |
| LIVN | LivaNova plcshares | $779,000 | +24.0% | 6,287 | 0.0% | 0.03% | +16.7% | |
| CYH | Community Health Systems, Inc. | $706,000 | +4.3% | 203,935 | 0.0% | 0.03% | 0.0% | |
| GMRE | Global Medical REIT Inc. | $691,000 | +6.3% | 73,400 | 0.0% | 0.02% | 0.0% | |
| Egalet Corporationnote 5.50% 4/1/20 | $700,000 | -71.4% | 7,000,000 | 0.0% | 0.02% | -73.1% | ||
| CDTX | Cidara Therapeutics, Inc. | $699,000 | -15.4% | 158,784 | 0.0% | 0.02% | -19.4% | |
| CLSD | Clearside Biomedical, Inc. | $508,000 | -42.5% | 82,665 | 0.0% | 0.02% | -47.1% | |
| NLNK | NewLink Genetics Corporation | $490,000 | -49.8% | 205,026 | 0.0% | 0.02% | -51.4% | |
| ABIO | ARCA biopharma, Inc. | $454,000 | +0.7% | 811,227 | 0.0% | 0.02% | -5.9% | |
| ALQA | Alliqua BioMedical, Inc. | $375,000 | +10.9% | 165,000 | 0.0% | 0.01% | +7.7% | |
| BLCM | Bellicum Pharmaceuticals, Inc. | $370,000 | -16.5% | 60,000 | 0.0% | 0.01% | -23.5% | |
| CAH | Cardinal Health, Inc. | $340,000 | +10.4% | 6,300 | 0.0% | 0.01% | 0.0% | |
| TBPH | Theravance Biopharma, Inc. | $264,000 | +44.3% | 8,083 | 0.0% | 0.01% | +42.9% | |
| NCNA | NuCana plcsponsored adr | $245,000 | +31.0% | 9,823 | 0.0% | 0.01% | +28.6% | |
| QHCCQ | Quorum Health Corporation | $139,000 | +16.8% | 23,725 | 0.0% | 0.01% | 0.0% | |
| CLDX | Celldex Therapeutics, Inc. | $48,000 | -9.4% | 105,800 | 0.0% | 0.00% | 0.0% | |
| JNCE | Jounce Therapeutics, Inc. | $66,000 | -15.4% | 10,127 | 0.0% | 0.00% | -33.3% |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2018-11-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Gilead Sciences, Inc. | 41 | Q2 2023 | 12.4% |
| Amgen, Inc. | 41 | Q2 2023 | 5.8% |
| Biogen Inc. | 41 | Q2 2023 | 6.5% |
| Vertex Pharmaceuticals Incorporated | 41 | Q2 2023 | 5.3% |
| Regeneron Pharmaceuticals, Inc. | 41 | Q2 2023 | 9.1% |
| Illumina, Inc. | 41 | Q2 2023 | 3.4% |
| BioMarin Pharmaceutical Inc. | 41 | Q2 2023 | 2.9% |
| Teva Pharmaceutical Industries Ltd. | 41 | Q2 2023 | 3.2% |
| Neurocrine Biosciences, Inc. | 41 | Q2 2023 | 1.4% |
| McKesson Corporation | 41 | Q2 2023 | 2.2% |
View Tekla Capital Management LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Rallybio Corp | January 23, 2023 | 1,727,067 | 4.6% |
| Zyla Life SciencesSold out | January 29, 2021 | 0 | 0.0% |
| ARCA biopharma, Inc. | January 24, 2020 | 36,068 | 2.3% |
| Verona Pharma plc | February 12, 2019 | 5,296,845 | 4.9% |
| Alliqua BioMedical, Inc. | February 12, 2018 | 165,000 | 3.3% |
| PIERIS PHARMACEUTICALS, INC. | February 12, 2018 | 1,962,380 | 4.4% |
| Intellipharmaceutics International Inc. | February 13, 2015 | 2,184,000 | 9.0% |
| HERON THERAPEUTICS, INC. /DE/ | February 14, 2014 | 20,598,613 | 4.2% |
| MEDWAVE INC | February 14, 2012 | 1,277,372 | 9.8% |
| MZT Holdings, Inc. | February 14, 2012 | 2,553,420 | 4.0% |
View Tekla Capital Management LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2023-08-10 |
| 13F-HR | 2023-05-10 |
| 13F-HR | 2023-02-10 |
| SC 13G/A | 2023-01-23 |
| 13F-HR | 2022-11-01 |
| 13F-HR | 2022-07-29 |
| 13F-HR | 2022-05-13 |
| 13F-HR | 2022-02-14 |
| SC 13G | 2022-01-21 |
| 13F-HR | 2021-11-12 |
View Tekla Capital Management LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.